ImetelChat

Glad to see you here.

Glad to see you here

Any thoughts on raise maybe new company?

My problem is why did Janessan want to do a trial in MF r/r why not do similar study as the Mayo? It just seems to me uncharted waters however i can't see Janessan walking away from imetelstat there is so much facts in the science of the drug that i think can be used in other indications with the co...

Thanks, for your informative response I'm still to this day not sure why J&J took on r/r MF and I personally don't expect good results from this 2nd interim review based on these patients. I'm hoping that they will realize a longer study is needed to see results from imetelstat

Ok, sorry for the repost.

Credit goes to et on ymb if so. http://www.freshpatents.com/-dt20170223 ... 051287.php

Thanks, not sure if anyone else finds this encouraging but for 4 years of data that some are still aLive is encouraging none the less.

robtmsstt1 wrote:I wanted to but ymb won't let me copy paste but it is mentioned 40 patients added total 81 with completion date May 2017 .

Also last updated Dec 2016 I believe its the Mayo study its 4 years old that will be presented to FDA.

I wanted to but ymb won't let me copy paste but it is mentioned 40 patients added total 81 with completion date May 2017 .

Is it true this trial is ongoing and they added more patients?

Thanks, fish im just trying to figure why do the presentation on the 3rd unless some pertinent news will come of it about the AML study.

Or is this just to inform shareholders on this study if done and what imetelstat will be used with if an AML study was to move forward?

Yes, they are either patients who responded to Jakafi and then stopped responding or failed to respond in the first place. In other words end stage disease with failure to respond to conventional therapy. They have about a seven month life expectancy. bp Thanks, biopearl i guess i was misled on YMB...

Are the patients in the J@J study worse in their condition than the one used in the MAYO study?

Very good sign I think that's why the pps has not been fluctuating.

Thanks, Fish hope to hear this one since nothing has been posted on Dr. T presentation.

Thanks, fish looking forward to start of AML study.

Ask Anna what "emerging trends" actually signify my interpretation of this statement says the patients are feeling better or there are signs the drug is working .

Still have Dr.T speaking maybe something from that will be encouraging.